CALA News and Press, Calithera Biosciences Inc. From 04/16/20

Calithera Biosciences (NASDAQ: CALA ) prices its public offering and sells 5M common shares at $6.25/share, for expected gross proceeds of $31.25M. More news on: Calithera Biosciences, Inc., Healthcare stocks news, , Stocks on the move, Read more ...

SOUTH SAN FRANCISCO, Calif., April 16, 2020 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-threatening diseases, today announce...

Gainers: RCUS   +49.2% .   LTRPB   +13.1% . CGEN   +15.9% . AM   +15.3% . BBBY   +12.1% . More news on: Arcus Biosciences, Inc., Liberty TripAdvisor Holdings, Inc., Compugen Ltd., Stocks on the move, , Read more ...

SOUTH SAN FRANCISCO, April 14, 2020 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering and developing novel small-molecule drugs for the treatment of cancer and other life-threatening diseases, shared an update on bu...

SCWorx  (NASDAQ: WORX ) +171%  on order for 2M COVID-19 blood tests. More news on: SCWorx Corp., Can-Fite BioPharma Ltd., Independence Contract Drilling, Inc., Stocks on the move, , Read more ...

Introduction The Weekly Breakout Forecast continues my doctoral research analysis on MDA breakout selections over more than 5 years. This subset of the different portfolios I regularly analyze has now reached 150 weeks of public selections as part of this ongoing live forward-testing. In...

Calithera Biosciences (NASDAQ: CALA ) initiated with Buy rating and $6 (34% upside) price target at Jefferies. More news on: Calithera Biosciences, Inc., bluebird bio, Inc., Charles River Laboratories International, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

Introduction The Weekly Breakout Forecast continues my doctoral research analysis on MDA breakout selections over more than 5 years. This subset of the different portfolios I regularly analyze has now reached 148 weeks of public selections as part of this ongoing live forward-testing. In...

Calithera Biosciences, Inc. (CALA) Q4 2019 Earnings Conference Call March 11, 2020 5:00 PM ET Company Participants Jennifer McNealey - Vice President of Investor Relations and Strategy Susan Molineaux - Founder, President & Chief Executive Officer Keith Orford - Chief Medical...

Calithera Biosciences (NASDAQ: CALA ): Q4 GAAP EPS of -$0.39 misses by $0.02 . More news on: Calithera Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...